found through WGCNA that CD14 and CSF1R showed high expression levels in osteoarthritis [6] and gastritis, highlighting CD14 and CSF1R as promising therapeutic targets for treating OA and gastritis [20]. This evidence concerns the gene CD14 and gastritis.